UA94716C2 - Calcium-peptide component for reducing body weight - Google Patents

Calcium-peptide component for reducing body weight

Info

Publication number
UA94716C2
UA94716C2 UAA200801548A UAA200801548A UA94716C2 UA 94716 C2 UA94716 C2 UA 94716C2 UA A200801548 A UAA200801548 A UA A200801548A UA A200801548 A UAA200801548 A UA A200801548A UA 94716 C2 UA94716 C2 UA 94716C2
Authority
UA
Ukraine
Prior art keywords
calcium
peptide component
body weight
reducing body
peptide
Prior art date
Application number
UAA200801548A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марко Зелль
Дирк Бодэ
Гюнтер Заватцки
Original Assignee
Хумана Мильхунион Эг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хумана Мильхунион Эг filed Critical Хумана Мильхунион Эг
Publication of UA94716C2 publication Critical patent/UA94716C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a calcium-peptide component which is obtainable from at least one calcium salt, caseinophosphopeptide and glycomacropeptide. It is possible to use the principle of milk, large amounts of the calcium bonding to proteins.
UAA200801548A 2005-07-19 2006-05-31 Calcium-peptide component for reducing body weight UA94716C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005033630A DE102005033630A1 (en) 2005-07-19 2005-07-19 Calcium-peptide component

Publications (1)

Publication Number Publication Date
UA94716C2 true UA94716C2 (en) 2011-06-10

Family

ID=37575596

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200801548A UA94716C2 (en) 2005-07-19 2006-05-31 Calcium-peptide component for reducing body weight

Country Status (5)

Country Link
EP (1) EP1903895A2 (en)
DE (1) DE102005033630A1 (en)
EA (1) EA016259B1 (en)
UA (1) UA94716C2 (en)
WO (1) WO2007009529A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
DE102006052560B4 (en) * 2006-11-06 2010-01-21 Humana Milchunion Eg Anti-diabetogenic calcium peptide composition
DE102007022694A1 (en) 2007-05-11 2008-11-13 Humana Milchunion Eg Milk fat milk protein composition to improve calcium absorption
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CN103445045A (en) * 2012-05-30 2013-12-18 孔徐生 Food composition having function of promoting calcium absorption and preparation method thereof
CN109805417A (en) * 2019-03-01 2019-05-28 河南九九一生物科技有限公司 A kind of health food that can increase bone density and its processing method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3373544B2 (en) * 1991-12-05 2003-02-04 明治乳業株式会社 Foods and drinks and pharmaceuticals with excellent calcium utilization that have the effect of alleviating dysmenorrhea
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
WO2001078533A2 (en) * 2000-04-18 2001-10-25 Société des Produits Nestlé S.A. Nutritional modules
US6384087B1 (en) * 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
GB0100273D0 (en) * 2001-01-08 2001-02-14 Nestle Sa Nutritional composition for a bone condition
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
JP2003048843A (en) * 2002-07-17 2003-02-21 Meiji Milk Prod Co Ltd Functional food for preventing and/or treating dysmenorrhea

Also Published As

Publication number Publication date
WO2007009529A2 (en) 2007-01-25
EA016259B1 (en) 2012-03-30
EA200800205A1 (en) 2008-08-29
DE102005033630A1 (en) 2007-01-25
EP1903895A2 (en) 2008-04-02
WO2007009529A3 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
UA94716C2 (en) Calcium-peptide component for reducing body weight
NL301089I1 (en)
TW200626171A (en) Fixed dosing of HER antibodies
EA200702109A1 (en) ALKINILPYRROPOLYRIDIDINES AND THEIR APPLICATION AS HSP90 INHIBITORS
TW200626068A (en) Active compounds for seed treatment
MXPA04000173A (en) Peptide-based compounds.
WO2007046006A3 (en) Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15rbeta/gamma, and hyperagonist (ilralpha sushi-il 15) fusion proteins
IL184424A0 (en) Cxcr4 antagonists for the treatment of hiv infection
WO2007150015A3 (en) Method of treatment
WO2007082923A3 (en) Use of protein microbeads in cosmetics
WO2011003100A3 (en) Compositions and methods for diagnosing and/or treating influenza infection
EP1863495A4 (en) Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
WO2006128143A3 (en) Hydantoin compounds
PL1922128T3 (en) Element for reducing the particulate matter content of air by the use of mosses and/or lichens
PL1987357T3 (en) Polypeptides recognized by anti-trichinella antibodies, and uses thereof
MX2009009952A (en) Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidiï¿-1-vï¿-5-m ethyl-2.2- diphenylhexanamide.
TW200700085A (en) Endoparasiticidal compositions
MA32717B1 (en) N- [6-CIS- (2,6-DIMETHYLMORPHOLIN-4-YL) PYRIDIN-3-YL) -2-METHYL-4'- (TRIFLUOROMETHOXY) - [1,1'-BIPHENYL] -3-CARBOXAMIDE SALTS
WO2008013983A3 (en) Opsin stabilizing compounds and methods of use
WO2007103584A3 (en) Polyamides for treating human papilloma virus
WO2010012940A3 (en) Microparticulate oral drug form useful for the modified release of nanoparticles
EP4218786A3 (en) Opiorphin for use as analgesic agent
TW200640376A (en) Reduction of digestibility of phosphorus
RU2007100727A (en) CERAMIC MASS
HK1171027A1 (en) Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof hiv